Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Abstract
Variable regions 1 and 2 (V1/V2) of human immunodeficiency virus-1 (HIV-1) gp120 envelope glycoprotein are critical for viral evasion of antibody neutralization, and are themselves protected by extraordinary sequence diversity and N-linked glycosylation. Human antibodies such as PG9 nonetheless engage V1/V2 and neutralize 80% of HIV-1 isolates. Here we report the structure of V1/V2 in complex with PG9. V1/V2 forms a four-stranded β-sheet domain, in which sequence diversity and glycosylation are largely segregated to strand-connecting loops. PG9 recognition involves electrostatic, sequence-independent and glycan interactions: the latter account for over half the interactive surface but are of sufficiently weak affinity to avoid autoreactivity. The structures of V1/V2-directed antibodies CH04 and PGT145 indicate that they share a common mode of glycan penetration by extended anionic loops. In addition to structurally defining V1/V2, the results thus identify a paradigm of antibody recognition for highly glycosylated antigens, which-with PG9-involves a site of vulnerability comprising just two glycans and a strand.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Sometimes, such protective glycosylation can become so dense that it generates unique clustered epitopes recognized by speci fi c antibodies, such as that seen on the surface of the HIV virion (507 -509, 594).”
From Biological roles of glycans (2017) · cites this paper as [507]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612 · cited 1×
“and a molecular replacement solution for the 1FD6-ZM109 data set consisting of two unbound PG9 Fab molecules per asymmetric unit was obtained using PHASE”
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Overview of the CCP 4 suite and current developments
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910045749 · Cited by 12,353
Inference of Macromolecular Assemblies from Crystalline State
Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 9,984
Nicholls, A., Sharp, K. A., & Honig, B. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110407 · Cited by 5,240
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J., Richardson, J. S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm216 · Cited by 3,896
The Anatomy and Taxonomy of Protein Structure
Richardson, J. S. (1981) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60520-3 · Cited by 3,375
Sequences of proteins of immunological interest
(1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90805-4 · Cited by 3,363
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,964
Self-citationAnalytical molecular surface calculation
Connolly, M. L. (1983) · Journal of Applied Crystallography · doi:10.1107/s0021889883010985 · Cited by 2,508
Automated molecular microscopy: The new Leginon system
Suloway, C., Pulokas, J., Fellmann, D., Cheng, A., Guerra, F., Quispe, J., Stagg, S., Potter, C. S., & Carragher, B. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.03.010 · Cited by 1,764 · cited 1×
“5 mm onto a Gatan 4k × 4k CCD using the Leginon packag”
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Self-citationThe HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
Wyatt, R., & Sodroski, J. (1998) · Science · doi:10.1126/science.280.5371.1884 · Cited by 1,598 · cited 1×
“ppt"/> As the sole viral target of neutralizing antibodies, the HIV-1 viral spike has evolved to evade antibody-mediated neutralization (reviewed in ref”
Self-citationBroad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
Self-citationMayer, M., & Meyer, B. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0100120 · Cited by 1,200 · cited 1×
“The STD amplification factor, A STD , was obtained according to the equation, A STD = ( I 0 – I SAT ) I 0 −1 (l L t r/l P r), where L t and P are the total ligand and protein concentrations, respectivel”
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Zhou, T., Georgiev, I., Wu, X., Yang, Z.-Y., Dai, K., Finzi, A., Do Kwon, Y., Scheid, J. F., Shi, W., Xu, L., et al. (2010) · Science · doi:10.1126/science.1192819 · Cited by 1,130 · cited 1×
“The epitopes for antibodies b12 and VRC01, for example, are comprised of seven and six independent protein segment”
Self-citationAppion: An integrated, database-driven pipeline to facilitate EM image processing
Lander, G. C., Stagg, S. M., Voss, N. R., Cheng, A., Fellmann, D., Pulokas, J., Yoshioka, C., Irving, C., Mulder, A., Lau, P.-W., et al. (2009) · Journal of Structural Biology · doi:10.1016/j.jsb.2009.01.002 · Cited by 835
Molecular architecture of native HIV-1 gp120 trimers
Liu, J., Bartesaghi, A., Borgnia, M. J., Sapiro, G., & Subramaniam, S. (2008) · Nature · doi:10.1038/nature07159 · Cited by 816 · cited 1×
“Localized by electron microscopy to a membrane-distal ‘cap&rsquo”
Structural definition of a conserved neutralization epitope on HIV-1 gp120
Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S.-H., Yang, X., Zhang, M.-Y., Zwick, M. B., Arthos, J., et al. (2007) · Nature · doi:10.1038/nature05580 · Cited by 770
Self-citationStructure of a V3-Containing HIV-1 gp120 Core
Huang, C.-C., Tang, M., Zhang, M.-Y., Majeed, S., Montabana, E., Stanfield, R. L., Dimitrov, D. S., Korber, B., Sodroski, J., Wilson, I. A., et al. (2005) · Science · doi:10.1126/science.1118398 · Cited by 731
Self-citationA Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Pejchal, R., Doores, K. J., Walker, L. M., Khayat, R., Huang, P.-S., Wang, S.-K., Stanfield, R. L., Julien, J.-P., Ramos, A., Crispin, M., et al. (2011) · Science · doi:10.1126/science.1213256 · Cited by 694
Self-citationReeves, P. J., Callewaert, N., Contreras, R., & Khorana, H. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212519299 · Cited by 640 · cited 1×
“Scaffold-V1/V2 heterogeneity was apparent after expression in GnTI −/− cell”
Arthos, J., Cicala, C., Martinelli, E., Macleod, K., Van Ryk, D., Wei, D., Xiao, Z., Veenstra, T. D., Conrad, T. P., Lempicki, R. A., et al. (2008) · Nature Immunology · doi:10.1038/ni1566 · Cited by 580 · cited 1×
“24 )) were also recognized by the a 4 b 7 integri”
Self-citationStructure of an unliganded simian immunodeficiency virus gp120 core
Chen, B., Vogan, E. M., Gong, H., Skehel, J. J., Wiley, D. C., & Harrison, S. C. (2005) · Nature · doi:10.1038/nature03327 · Cited by 520
Radermacher, M., Wagenknecht, T., Verschoor, A., & Frank, J. (1987) · Journal of Microscopy · doi:10.1111/j.1365-2818.1987.tb01333.x · Cited by 501
Gray, E. S., Madiga, M. C., Hermanus, T., Moore, P. L., Wibmer, C. K., Tumba, N. L., Werner, L., Mlisana, K., Sibeko, S., Williamson, C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00198-11 · Cited by 466
Mitsuya, H., Looney, D. J., Kuno, S., Ueno, R., Wong-Staal, F., & Broder, S. (1988) · Science · doi:10.1126/science.2452480 · Cited by 463 · cited 1×
“This conserved cationic character—present in the target-cell-facing V1/V2 cap of the viral spike—may relate to the observed anionic interactions of the viral spike, both with dextran sulphat”
Bonsignori, M., Hwang, K.-K., Chen, X., Tsao, C.-Y., Morris, L., Gray, E., Marshall, D. J., Crump, J. A., Kapiga, S. H., Sam, N. E., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05045-11 · Cited by 423
Self-citationStructures of HIV-1 gp120 Envelope Glycoproteins from Laboratory-Adapted and Primary Isolates
Kwong, P. D., Wyatt, R., Majeed, S., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (2000) · Structure · doi:10.1016/s0969-2126(00)00547-5 · Cited by 390 · cited 1×
“The V1/V2 structure, in the context of scaffold and PG9, folds as four anti-parallel b-strands (labelled A, B, C, D) arranged in (21, 21, 13) topology(28) (Fig.”
Self-citationWalker, L. M., Simek, M. D., Priddy, F., Gach, J. S., Wagner, D., Zwick, M. B., Phogat, S. K., Poignard, P., & Burton, D. R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001028 · Cited by 370 · cited 1×
“The V1/V2 structure, in the context of scaffold and PG9, folds as four anti-parallel b-strands (labelled A, B, C, D) arranged in (21, 21, 13) topology(28) (Fig.”
Self-citationRosettaRemodel: A Generalized Framework for Flexible Backbone Protein Design
Huang, P.-S., Ban, Y.-E. A., Richter, F., Andre, I., Vernon, R., Schief, W. R., & Baker, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024109 · Cited by 369
Self-citationPancera, M., Majeed, S., Ban, Y.-E. A., Chen, L., Huang, C.-C., Kong, L., Kwon, Y. D., Stuckey, J., Zhou, T., Robinson, J. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911004107 · Cited by 338 · cited 1×
“of HIV-1 gp120 with V1/V2 was attempted following strategies that were successful for structural determination of other portions of HIV-1 gp120 (ref”
Self-citationMondor, I., Ugolini, S., & Sattentau, Q. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3623-3634.1998 · Cited by 309
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
Chen, L., Do Kwon, Y., Zhou, T., Wu, X., O’Dell, S., Cavacini, L., Hessell, A. J., Pancera, M., Tang, M., Xu, L., et al. (2009) · Science · doi:10.1126/science.1175868 · Cited by 300
Self-citationMoulard, M., Lortat-Jacob, H., Mondor, I., Roca, G., Wyatt, R., Sodroski, J., Zhao, L., Olson, W., Kwong, P. D., & Sattentau, Q. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.4.1948-1960.2000 · Cited by 297
Self-citationSPIDER—A modular software system for electron image processing
Frank, J., Shimkin, B., & Dowse, H. (1981) · Ultramicroscopy · doi:10.1016/s0304-3991(81)80221-5 · Cited by 282
Pinter, A., Honnen, W. J., He, Y., Gorny, M. K., Zolla-Pazner, S., & Kayman, S. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5205-5215.2004 · Cited by 248 · cited 1×
“, which holds the spike in a neutralization-resistant conformation, V1/V2 is not essential for entry: its removal, however, renders the virus profoundly sensitive to antibody-mediated neutralizatio”
Pancera, M., McLellan, J. S., Wu, X., Zhu, J., Changela, A., Schmidt, S. D., Yang, Y., Zhou, T., Phogat, S., Mascola, J. R., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00966-10 · Cited by 224
Self-citationComputation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
Azoitei, M. L., Correia, B. E., Ban, Y.-E. A., Carrico, C., Kalyuzhniy, O., Chen, L., Schroeter, A., Huang, P.-S., McLellan, J. S., Kwong, P. D., et al. (2011) · Science · doi:10.1126/science.1209368 · Cited by 224
Self-citationCao, J., Sullivan, N., Desjardin, E., Parolin, C., Robinson, J., Wyatt, R., & Sodroski, J. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9808-9812.1997 · Cited by 219 · cited 1×
“, which holds the spike in a neutralization-resistant conformation, V1/V2 is not essential for entry: its removal, however, renders the virus profoundly sensitive to antibody-mediated neutralizatio”
Self-citationKarasavvas, N., Billings, E., Rao, M., Williams, C., Zolla-Pazner, S., Bailer, R. T., Koup, R. A., Madnote, S., Arworn, D., Shen, X., et al. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0103 · Cited by 211
Self-citationPejchal, R., Walker, L. M., Stanfield, R. L., Phogat, S. K., Koff, W. C., Poignard, P., Burton, D. R., & Wilson, I. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004600107 · Cited by 208
Self-citationSchols, D., Pauwels, R., Desmyter, J., & De Clercq, E. (1990) · Virology · doi:10.1016/0042-6822(90)90440-3 · Cited by 205 · cited 1×
“This conserved cationic character—present in the target-cell-facing V1/V2 cap of the viral spike—may relate to the observed anionic interactions of the viral spike, both with dextran sulphat”
Structural Rationale for the Broad Neutralization of HIV-1 by Human Monoclonal Antibody 447-52D
Stanfield, R. L., Gorny, M. K., Williams, C., Zolla-Pazner, S., & Wilson, I. A. (2004) · Structure · doi:10.1016/j.str.2004.01.003 · Cited by 194 · cited 1×
“This type of b-sheet interaction, for example, is the primary interaction between the CDR H3 of antibody 447-52D and the V3 of gp120 (ref”
Self-citationSpider—A modular software system for electron image processing
Frank, J., Shimkin, B., & Dowse, H. (1981) · Ultramicroscopy · doi:10.1016/s0304-3991(81)80236-7 · Cited by 175
White, T. A., Bartesaghi, A., Borgnia, M. J., Meyerson, J. R., de la Cruz, M. J. V., Bess, J. W., Nandwani, R., Hoxie, J. A., Lifson, J. D., Milne, J. L. S., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001249 · Cited by 167
Moore, P. L., Gray, E. S., Sheward, D., Madiga, M., Ranchobe, N., Lai, Z., Honnen, W. J., Nonyane, M., Tumba, N., Hermanus, T., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02658-10 · Cited by 159
Stamatatos, L., & Cheng‐Mayer, C. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.7840-7845.1998 · Cited by 152 · cited 1×
“, which holds the spike in a neutralization-resistant conformation, V1/V2 is not essential for entry: its removal, however, renders the virus profoundly sensitive to antibody-mediated neutralizatio”
Górny, M. K., Stamatatos, L., Volsky, B., Revesz, K., Williams, C. A. U., Wang, X., Cohen, S., Staudinger, R., & Zolla‐Pazner, S. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5232-5237.2005 · Cited by 148
Kwong, P. D., Wyatt, R. T., Desjardins, E., Robinson, J. E., Culp, J. S., Hellmig, B. D., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4115 · Cited by 112 · cited 1×
“Structure determination Variational crystallizatio”
Self-citationRusert, P., Krarup, A., Magnus, C., Brandenberg, O. F., Weber, J., Ehlert, A.-K., Regoes, R. R., Günthard, H. F., & Trkola, A. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110196 · Cited by 108
Unusual Binding Properties of the SH3 Domain of the Yeast Actin-binding Protein Abp1
Fazi, B., Cope, M. J. T. V., Douangamath, A., Ferracuti, S., Schirwitz, K., Zucconi, A., Drubin, D. G., Wilmanns, M., Cesareni, G., & Castagnoli, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109848200 · Cited by 104
Fox, J., Peters, B. S., Prakash, M., Arribas, J. R., Hill, A., & Moecklinghoff, C. (2010) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2010.0081 · Cited by 86
Fletcher, P. S., Wallace, G. S., Mesquita, P. M. M., & Shattock, R. J. (2006) · Retrovirology · doi:10.1186/1742-4690-3-46 · Cited by 78
Enhancing Protein Crystallization through Precipitant Synergy
Majeed, S., Ofek, G., Belachew, A., Huang, C.-C., Zhou, T., & Kwong, P. D. (2003) · Structure · doi:10.1016/s0969-2126(03)00185-0 · Cited by 77 · cited 1×
“Complexes of PG9 Fab bound to 1FD6-CAP45 or 1FD6-ZM109 crystallized in similar condition”
Self-citationHonnen, W. J., Krachmarov, C. P., Kayman, S. C., Górny, M. K., Zolla‐Pazner, S., & Pinter, A. (2006) · Journal of Virology · doi:10.1128/jvi.02054-06 · Cited by 63
He, X. M., Rüker, F., Casale, E., & CARTER, D. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7154 · Cited by 60
Single-particle cryoelectron microscopy analysis reveals the HIV-1 spike as a tripod structure
Wu, S.-R., Löving, R., Lindqvist, B., Hebert, H., Koeck, P. J. B., Sjöberg, M., & Garoff, H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007227107 · Cited by 56
Structural Comparison of HIV-1 Envelope Spikes with and without the V1/V2 Loop
Hu, G., Liu, J., Taylor, K. A., & Roux, K. H. (2010) · Journal of Virology · doi:10.1128/jvi.01612-10 · Cited by 52
Immunotypes of a Quaternary Site of HIV-1 Vulnerability and Their Recognition by Antibodies
Wu, X., Changela, A., O'Dell, S. J., Schmidt, S. D., Pancera, M., Yang, Y., Zhang, B., Górny, M. K., Phogat, S. K., Robinson, J. E., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02585-10 · Cited by 52
Self-citationChangela, A., Wu, X., Yang, Y., Zhang, B., Zhu, J., Nardone, G. A., O'Dell, S. J., Pancera, M., Górny, M. K., Phogat, S. K., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02335-10 · Cited by 50
Self-citationDissection of the protein G B1 domain binding site for human IgG Fc fragment
Sloan, D. J., & Hellinga, H. W. (1999) · Protein Science · doi:10.1110/ps.8.8.1643 · Cited by 49 · cited 1×
“Potential V1/V2 scaffolds were examined manually and, if necessary, optimizations were made to accommodate full-length V1/V2 loops (residues 126–196) or to alter scaffold properties (for example, mutating the intrinsic immunoglobulin affinity of 1FD6; ref”
Ross, S. A., Sarisky, C. A., Su, A., & Mayo, S. L. (2001) · Protein Science · doi:10.1110/ps.32501 · Cited by 36
Three-Dimensional Structure of the Fab from a Human IgM Cold Agglutinin
Cauerhff, A., Braden, B. C., Carvalho, J. G., Aparício, R., Polikarpov, I., Leoni, J., & Goldbaum, F. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6422 · Cited by 30
Spurrier, B., Sampson, J. M., Totrov, M. M., Li, H., O'Neal, T., Williams, C. A. U., Robinson, J. E., Górny, M. K., Zolla‐Pazner, S., & Kong, X. (2011) · Structure · doi:10.1016/j.str.2011.02.012 · Cited by 25
Research works printed but not linked: 3
- Karasavvas, N. et al. The Thai Phase III clinical trial (RV144) induces the generation of antibodies that target a conserved region within the V2 loop of gp120. AIDS Res. Hum. Retroviruses 27, A-29 (2011) · DOI
- Zolla-Pazner, S. et al. V2-reactive antibodies in RV144 vaccinees’ plasma. AIDS Res. Hum. Retroviruses 27, A-21 (2011)
- Otwinowski, Z. & Minor, W. in Methods Enzymol. Vol. 276, 307–326 (Academic Press, 1997)
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“Sometimes, such protective glycosylation can become so dense that it generates unique clustered epitopes recognized by specific antibodies, such as that seen on the surface of the HIV virion (507) (508) (509) 594) .”
BackgroundImmune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Haynes, B. F., Gilbert, P. B., McElrath, M. J., Zolla-Pazner, S., Tomaras, G. D., Alam, S. M., Evans, D. T., Montefiori, D. C., Karnasuta, C., Sutthent, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113425 · Cited by 1,808
Self-citationFUBAR: A Fast, Unconstrained Bayesian AppRoximation for Inferring Selection
Murrell, B., Moola, S., Mabona, A., Weighill, T., Sheward, D., Kosakovsky Pond, S. L., & Scheffler, K. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst030 · Cited by 1,358
“Several potent and broadly crossneutralizing HIV antibodies (PG9/ PG16-like and PGT128-like antibodies) are dependent on both a peptide and a glycan component for binding (McLellan et al. 2011; Pejchal et al. 2011), providing a precedent for this mode of recognition.”
BackgroundStructure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
McLellan, J. S., Chen, M., Joyce, M. G., Sastry, M., Stewart-Jones, G. B. E., Yang, Y., Zhang, B., Chen, L., Srivatsan, S., Zheng, A., et al. (2013) · Science · doi:10.1126/science.1243283 · Cited by 1,126
Self-citationCrystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
Julien, J.-P., Cupo, A., Sok, D., Stanfield, R. L., Lyumkis, D., Deller, M. C., Klasse, P.-J., Burton, D. R., Sanders, R. W., Moore, J. P., et al. (2013) · Science · doi:10.1126/science.1245625 · Cited by 797
“Antibody interactions additional to those previously described in the PG9/PG16-V1/V2-scaffold co-crystal structures (4, 6) are predicted to occur with gp120 V3, as well as with residues N160 and N197 of the adjacent protomer.”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- McLellan, J. S., Pancera, M., Carrico, C., Gorman, J., Julien, J.-P., Khayat, R., Louder, R., Pejchal, R., Sastry, M., Dai, K., O’Dell, S., Patel, N., Shahzad-ul-Hussan, S., Yang, Y., Zhang, B., Zhou, T., Zhu, J., Boyington, J. C., Chuang, G.-Y., Diwanji, D., Georgiev, I., Do Kwon, Y., Lee, D., Louder, M. K., Moquin, S., Schmidt, S. D., Yang, Z.-Y., Bonsignori, M., Crump, J. A., Kapiga, S. H., Sam, N. E., Haynes, B. F., Burton, D. R., Koff, W. C., Walker, L. M., Phogat, S., Wyatt, R., Orwenyo, J., Wang, L.-X., Arthos, J., Bewley, C. A., Mascola, J. R., Nabel, G. J., Schief, W. R., Ward, A. B., Wilson, I. A., & Kwong, P. D.
- Affiliations
- National Institutes of Health (US)
- University of Washington (US)
- Scripps Research Institute (US)
- Duke University (US)
- Tumaini University (TZ)
- International AIDS Vaccine Initiative (US)
- University of Maryland, Baltimore (US)
- Corresponding author
- Kwong, Peter D.
- ORCID
- McLellan, Jason S.
- Pancera, Marie
- Carrico, Chris
- Gorman, Jason
- Julien, Jean-Philippe
- Khayat, Reza
- Louder, Robert
- Patel, Nikita
- Yang, Yongping
- Zhang, Baoshan
- Zhou, Tongqing
- Zhu, Jiang
- Boyington, Jeffrey C.
- Chuang, Gwo-Yu
- Diwanji, Devan
- Georgiev, Ivelin
- Louder, Mark K.
- Moquin, Stephanie
- Schmidt, Stephen D.
- Bonsignori, Mattia
- Crump, John A.
- Kapiga, Saidi H.
- Haynes, Barton F.
- Burton, Dennis R.
- Koff, Wayne C.
- Walker, Laura M.
- Wyatt, Richard
- Wang, Lai-Xi
- Arthos, James
- Bewley, Carole A.
- Mascola, John R.
- Nabel, Gary J.
- Schief, William R.
- Ward, Andrew B.
- Wilson, Ian A.
- Kwong, Peter D.
- Venue
- Nature
- Published
- 2011-11-23
- Volume
- 480
- Issue
- 7377
- Pages
- 336-343
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3406929
- OpenAlex
- W2122617162
- Cited by
- 830
- References
- 69
- Citations by year
- 2026: 22 · 2025: 21 · 2024: 23 · 2023: 25 · 2022: 36 · 2021: 38 · 2020: 39 · 2019: 52 · 2018: 63 · 2017: 70 · 2016: 64 · 2015: 84 · 2014: 92 · 2013: 120 · 2012: 78
- FWCI
- 36.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Funders
- U.S. Department of Energy (W - 31 - 109 - Eng - 38)
- International AIDS Vaccine Initiative
- Ragon Institute of MGH, MIT and Harvard
- National Institutes of Health
- Office of Science (W-31-109-ENG-38)
- Canadian Institutes of Health Research
- National Institute of Allergy and Infectious Diseases (R01AI033292, R01AI084817)
- National Center for Research Resources (RR017573, P41RR017573)
- Basic Energy Sciences (W-31-109-Eng38)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Keywords
- HIV-1 gp120, antibody-antigen complex structure, N-glycosylation, carbohydrate recognition, HIV vaccine development, envelope glycoprotein
- MeSH terms
- Amino Acid Sequence, Antibody Affinity, Antibody Specificity, Antigen-Antibody Complex, Epitopes, Binding Sites, Antibody, Glycopeptides, Glycosylation, Hydrogen Bonding, Models, Molecular, Molecular Sequence Data, Polysaccharides, HIV Antibodies, HIV-1, HIV Envelope Protein gp120, AIDS Vaccines, Conserved Sequence, Protein Structure, Tertiary, Crystallography, X-Ray, Amino Acid Motifs, Protein Structure, Quaternary, Immune Evasion, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.